On 1 April 2026, the first wave of ICB mergers took effect. Twelve existing Integrated Care Boards were abolished and six new ones established in their place, with an additional boundary change on top. For independent sector providers bidding for NHS-funded contracts, the practical reality shifted overnight. The contact person who guided your last bid may have transferred or taken voluntary exit. The procurement plan you were tracking may now sit with a commissioner who does not yet have a settled pipeline. The contract you were preparing to defend may now be held by a different ICB.

That change is not arriving on its own. The NHS Standard Contract 2026/27 was published by NHS England on 28 January 2026 with material changes to escalation, activity management, and quality requirements. The Provider Selection Regime, in force since January 2024, is now the dominant procurement route for almost every NHS healthcare contract. NHS England itself is mid-abolition, with its functions being absorbed into the Department of Health and Social Care.

This guide pulls the three threads together. It covers what changed in the NHS Standard Contract 2026/27, how the Provider Selection Regime works in practice, what ICB consolidation means for your bid pipeline, and how to position your tender responses under each PSR route. The principles in winning UK care tenders still apply, but the procurement environment they apply to has changed.

What changed in the NHS Standard Contract 2026/27

The NHS Standard Contract is mandated by NHS England for use by NHS commissioners for all contracts for healthcare services other than primary care. Both full-length and shorter-form versions apply. The final 2026/27 versions were published on 28 January 2026 after consultation closed on 16 December 2025. The changes that matter most to independent sector providers are concentrated in activity management, quality requirements, and contract governance.

Removal of the contractual escalation process. Under previous versions of the Contract, providers had a route to refer disputes about Indicative Activity Plans (IAPs) and Activity Management Plans (AMPs) to an independent panel where the commissioner had not complied with the technical guidance. In 2025/26, that panel found in favour of providers in around half of escalations. From 2026/27, the contractual escalation route has been removed. Disputes now run through normal contract dispute resolution, which means a provider seeking to challenge a commissioner decision must rely on dispute resolution and, if necessary, legal proceedings for breach of contract.

Strengthened commissioner contract management powers. Where a provider does not engage with the contract management process or fails to attend Joint Activity Reviews, commissioners can now withhold up to 10 per cent of the expected or actual monthly contract value, and continue to withhold for each further month the failure persists.

Reduced AMP timescales. Where the provider and commissioner cannot agree an AMP at a Joint Activity Review, or the provider does not attend without reasonable notice or explanation, the commissioner can now set the AMP from the next operational day, rather than the previous 10 operational days.

Greater weight to commissioner obligations. Paragraphs 42.25 and 42.38 of the Technical Guidance, which commissioners were previously required only to “take into account,” are now contractual obligations the commissioner must comply with.

Local variations to National Quality Requirements. For 2026/27, commissioners can set local variations to certain NQRs where agreed with NHS England as part of the annual planning round. Where a local target is set, it takes precedence over the national requirement. Affected requirements include the 18-week referral to treatment target and diagnostic test waiting times.

New optional Schedule 2N: Health Inequalities Action Plan. Commissioners and providers can agree to incorporate a Health Inequalities Action Plan into the contract, supporting NHS England and ICB statutory duties to reduce health inequalities.

Martha’s Rule implementation. NHS Trusts and Foundation Trusts will be required to implement the three core components of Martha’s Rule, the patient safety initiative enabling rapid review on patient or family request, by 31 March 2027.

Updated National Quality Requirements to reflect new metrics in the Medium Term Planning Framework 2026/27 to 2028/29, particularly for cancer and elective care.

For independent sector providers, the practical net effect is that the contract management balance has shifted toward the commissioner. The defensive escalation tool that providers relied on in 2025/26 is gone. The deadline for agreeing an IAP for 2026/27 was 1 April for existing contracts, or before service commencement for new ones.

The Provider Selection Regime: how it works in 2026

The Provider Selection Regime came into force on 1 January 2024 under the Health Care Services (Provider Selection Regime) Regulations 2023, made under the Health and Care Act 2022. It removed the procurement of NHS healthcare services from the scope of the Public Contracts Regulations 2015. When the Procurement Act 2023 came into force on 24 February 2025, healthcare services in scope of the PSR remained out of scope of the Procurement Act, except where exclusion provisions apply. The PSR statutory guidance was last updated in April 2025 to reflect the Procurement Act and to clarify the most suitable provider process.

The PSR applies to relevant authorities: ICBs, NHS England, NHS Trusts, NHS Foundation Trusts, local authorities, and combined authorities. It applies to all healthcare services they commission, regardless of who provides them.

Five provider selection processes operate under the PSR:

• Direct Award Process A: used where there is only one capable provider for the service. The commissioner can award without competition.
• Direct Award Process B: used where patients have an unrestricted right to choose between providers, for example certain elective services.
• Direct Award Process C: used where an existing provider is satisfying its contract and the new contract will not be materially different from the current one. This is the most common direct award route for incumbent providers and the one that affects existing AssuredBID clients most.
• Most Suitable Provider Process: the commissioner judges who is most suitable based on the five key criteria, without a formal competitive tender.
• Competitive Process: a formal competitive tender, used where competition is judged to deliver the best outcome, or where the most suitable provider process did not identify a clear winner.

When making decisions under Direct Award C, the Most Suitable Provider Process, or the Competitive Process, the commissioner must consider five key criteria:

• Quality and innovation
• Value
• Integration, collaboration, and service sustainability
• Improving access, reducing health inequalities, and facilitating choice
• Social value

After publishing an intention-to-award notice on Find a Tender, the commissioner must observe an eight-working-day standstill period during which other providers can make representations. If the commissioner does not respond satisfactorily, the disappointed provider can refer the decision to the Independent Patient Choice and Procurement Panel, which can advise the commissioner on changes to its decision-making.

For independent sector providers, the PSR creates both opportunity and risk. The opportunity is that contracts can be retained or extended directly with incumbents who are performing well, without recompetition. The risk is that contracts can be awarded directly to other providers you cannot bid against, unless you make a focused, evidenced representation in the standstill window.

What ICB consolidation means for your bid pipeline

The wider NHS reorganisation announced on 13 March 2025 has reached its first practical milestone. From 1 April 2026, the number of ICBs is dropping from 42 to 26 through a phased programme: six new ICBs replaced twelve in Phase 1 on 1 April 2026, with the remaining mergers to take effect on 1 April 2027.

Running alongside the mergers:

• ICB management budgets have been cut by 50 per cent, with redundancies completing by April 2026
• ICBs are being repositioned as strategic commissioners focused on population health management and outcomes, with operational commissioning functions moving to regional bodies, trusts, or new “neighbourhood health providers”
• Specialised commissioning is transferring to seven ICB hubs from April 2026
• Integrated Care Partnerships, Healthwatch England, Commissioning Support Units, the Health Services Safety Investigations Body, and around 200 other NHS organisations are being abolished
• NHS England itself is being abolished, with its remaining functions absorbed into the Department of Health and Social Care; combined NHS England and DHSC headcount is being roughly halved

For independent sector providers bidding for NHS-funded contracts, the practical implications are concrete:

• Existing contracts have transferred. Where an ICB has been abolished, all contracts, staff, property, and liabilities pass to the successor ICB through a transfer scheme under section 14Z28 of the National Health Service Act 2006. The successor ICB is the new contracting party and the new data controller. Reporting routes, billing details, and contact relationships need rebuilding.
• Procurement plans are slipping. With management budgets halved and staff in restructure, ICB procurement teams have less capacity. Some planned procurements have been deferred into late 2026 or 2027.
• Strategic commissioning means longer time horizons and outcomes-based contracts. ICBs are being asked to commission for population health outcomes rather than transactional service contracts. Providers that can articulate outcomes evidence have an advantage.
• Specialised commissioning is concentrating. Continuing healthcare, complex case management, and other specialised services are moving to the seven ICB hubs. The number of relationships providers need to maintain is reducing, but each relationship is becoming more important.
• The neighbourhood health provider concept is unsettled. New bodies forming around primary care networks are expected to take on operational delivery, but the legal and contractual framework is still being developed.

For NHS-focused bid writing in 2026, three things follow: pipeline tracking has to be more dynamic; relationships with new commissioners need building early rather than waiting for tender notices; and bid responses need to align with the strategic commissioning direction (outcomes, population health, integration), not only with the historic operational specification.

How to position your bid under each PSR route

The PSR route a commissioner chooses changes how you should write the bid, or in some cases, the representation. The most common scenario for established providers is Direct Award Process C, where the incumbent has the gateway and competitors must use the standstill window to challenge.

Direct Award C (incumbent position): the bid is your performance evidence. Commissioners need to demonstrate that the existing provider is satisfying its contract and the new contract will not be materially different. Strong incumbent positioning includes KPI compliance and performance data over the existing contract term, CQC rating evidence and trajectory, service user satisfaction data with named feedback mechanisms, demonstrated alignment with the five key criteria, and evidence of innovation and continuous improvement.

Direct Award C (challenger representation): the standstill representation must be specific, evidenced, and focused on the relevant authority’s compliance with the PSR, not on whether you would deliver a better service. A strong representation cites the regulation, the criterion, and the evidence the relevant authority did not adequately consider before reaching its decision.

Most Suitable Provider Process: the commissioner is making a comparative judgment without a competitive tender. Providers wanting to be considered need to ensure the commissioner has up-to-date evidence of capability against all five key criteria before the decision is taken. This is where pre-tender market engagement matters more than the formal response.

Competitive Process: behaves more like a traditional tender. The five key criteria are weighted and scored, and the commissioner must run an open and fair process. The same principles that apply to local authority tenders apply here. Reading the specification carefully, identifying the golden thread, evidencing every claim, and aligning with what the commissioner is actually trying to achieve all carry through.

Common mistakes when bidding for NHS contracts in 2026

Patterns that cost providers contracts in the current environment:

• Bidding to the wrong commissioner. Tender notices, contact details, and submission portals from before 1 April 2026 may now reference abolished ICBs. Verify the current commissioning entity before submission.
• Treating the PSR like the old Public Contracts Regulations. The five key criteria are not the same as MEAT scoring. Social value, integration, and reducing health inequalities are statutory criteria, not optional weighted extras.
• Missing the standstill period. Eight working days is short. Providers without a system for monitoring transparency notices on Find a Tender often discover decisions after the standstill has closed.
• Overlooking Direct Award C exposure. Incumbents can be replaced if the commissioner believes the contract has changed materially or the provider is no longer satisfying it. Challengers without a transparency-stage representation route in often have no route in at all.
• Not aligning with the strategic commissioning direction. Bids that read as transactional service descriptions, rather than outcomes-based propositions linked to population health, score lower with ICBs being repositioned as strategic commissioners.
• Underestimating Schedule 2N and Martha’s Rule. Both reflect commissioner priorities. Bids that engage substantively with health inequalities outcomes and patient safety expectations land more credibly than those that treat them as compliance ticks.

Real-world examples of how these principles play out in winning submissions are documented in AssuredBID’s case studies.

FAQ

Is the NHS Standard Contract 2026/27 mandatory for all NHS healthcare contracts? The NHS Standard Contract is mandated by NHS England for use by NHS commissioners (ICBs and NHS England) for all contracts for healthcare services other than primary care. The 2026/27 version was published on 28 January 2026 and applies to contracts running for the year from 1 April 2026.

Does the Provider Selection Regime apply to social care contracts? No. The PSR applies only to healthcare services in scope of the regulations. Social care contracts commissioned by local authorities sit outside the PSR and remain in scope of the Procurement Act 2023. Where a contract is mixed, combining healthcare and social care, the commissioner must determine which regime applies based on the predominant service value.

How do ICB mergers affect contracts that were already in place? Where an ICB has been abolished, all contracts, staff, property, and liabilities transfer to the successor ICB through a transfer scheme made under section 14Z28 of the National Health Service Act 2006. The successor ICB becomes the new contracting party and the new data controller. Providers should expect new contact details, reporting routes, and billing arrangements.

What is the standstill period under the PSR and how should I use it? After publishing an intention-to-award notice on Find a Tender, the relevant authority must observe an eight-working-day standstill period. During this period, other providers can make representations to the relevant authority. Effective representations are specific, cite the regulation and key criterion, and identify evidence the authority did not adequately consider. If those representations are not resolved, the disappointed provider can refer the decision to the Independent Patient Choice and Procurement Panel.

How should providers prepare for the rest of 2026? Three priorities. First, track NHS pipelines actively as ICB structures consolidate, including the seven specialised commissioning hubs. Second, build relationships with the new strategic commissioners early, before tender notices appear, particularly where ICBs have been abolished and replaced. Third, ensure your evidence base aligns with the five PSR key criteria, especially social value, health inequalities, and integration. Providers with structured evidence libraries are better positioned to respond quickly to direct award representations and most suitable provider opportunities.

Need support with tenders or compliance? AssuredBID helps UK social care providers prepare stronger bids and win the right opportunities.

You can book a consultation with our tender experts, explore our services, and follow AssuredBID on social media for practical updates, insights, and guidance you can actually use.